CJC-1295 NO DAC 5mg + Ipamorelin 5mg (Blend)

Peptide blend · GHRH analogue + GHS · Synthetic

Half-life

~30min / ~2h

After administration

Delivery Method

SubQ injection

Route of administration

Storage (Lyophilised)

12-24 months

2–8°C

Storage (Reconstituted)

4–6 weeks

Refrigerate at 2-8C

Known For

The gold standard GH secretagogue stack. Combines GHRH (CJC) with GHRP (Ipa) for synergistic GH release. Pulsatile, physiological GH elevation. Supports muscle growth, fat loss, sleep, recovery, skin quality.

Mechanism of Action

Gold standard secretagogue stack — GHRH (CJC) tells pituitary to release GH + GHSP (Ipa) amplifies the signal. Synergistic pulsatile GH release.

Body vs. External Supply

🟢 Secretagogue (stimulates natural)

Brand / Trade Names

No pharmaceutical brand Commonly compounded by 503B pharmacies FDA restricted compounding (2023)

Typical Research Dosage

4 units per dose (100mcg/100mcg per dose with 2ml BAC water). 2-3x daily fasted. Before bed is priority.

Vial Duration Guide

At 8-12 units/day = ~17-25 days per vial.

Recommended Vial Size

★ 5mg+5mg (only size) At 8-12 units/day (2ml BAC water) = 17-25 days ✓. Perfect shelf life fit.

Time to Effects

EARLY: 1-2 weeks FULL: 8-12 weeks Week 1-2: Improved deep sleep is usually the FIRST noticeable effect (especially bedtime dose). Vivid dreams. Better morning energy. Week 2-4: Faster recovery from training. Skin starts looking 'fuller'. Subtle fat loss beginning. Week 4-8: Noticeable body composition shift — less abdominal fat, better muscle tone. Skin quality improving. Injuries healing faster. Week 8-12: Full cumulative effect. Significant improvement in body composition, sleep, skin, recovery, and energy. Minimum commitment: 8 weeks. Optimal: 12-16 weeks for full assessment. Many run indefinitely for anti-aging.

Contraindications & Do Not Combine

• Do NOT combine with exogenous HGH • Do NOT combine with CJC-1295 DAC • Avoid adding another GHRP on top (Ipamorelin is already in the blend)

Common Side Effects

Flushing, mild headache, transient hunger — generally very well tolerated

Drug Interactions

Same as individual components

Reversibility

🟢 Fully reversible — both stimulate natural production

Key Peer-Reviewed References

All studies are published in indexed journals unless otherwise noted.

• Based on individual studies for each component (see CJC-1295 and Ipamorelin entries) • No published studies on the specific combination • Widely used in clinical practice (compounding pharmacies) • NOT FDA APPROVED as combination • FDA restricted compounding (2023)

Research Disclaimer

Almost all data is preclinical (animal or in-vitro). No large-scale randomised controlled human trials are available for most compounds on this catalogue. This information is provided for research reference only.

Storage Requirements

Reconstituted: 2-8°C, 14-21 days

State	Condition	Duration
Lyophilised (sealed)	2–8°C	12-24 months
Reconstituted	2-8C	4–6 weeks

Reconstitution Note

Reconstitute with bacteriostatic water (BAC water). Do not shake vigorously -- swirl gently to dissolve. Inject BAC water slowly down the side of the vial to avoid denaturing the peptide.

CJC-1295 NO DAC 5mg + Ipamorelin 5mg (Blend)

Select Vial Size

$115.00 per vial

Submit Your Test Results →

Quick Reference

Half-life	CJC: ~30 min \| Ipa: ~2hrs \| Combined effective window: 2-3hrs
Delivery	SubQ injection
Typical dose	100mcg
Storage (lyoph.)	2–8°C
Storage (recon.)	4–6 weeks
Endogenous?	Secretagogue (stimulates natural)
Suppression	None (stimulates GH)
WADA	Prohibited (S2)
FDA status	Category 2 (2023)